Cas:158178-35-9 1,2-difluoro-4-(trifluoromethoxy)benzene manufacturer & supplier

Chemical Name:1,2-difluoro-4-(trifluoromethoxy)benzene

CAS.NO:158178-35-9

Synonyms:1,2-DIFLUORO-4-TRIFLUOROMETHOXYBENZENE;1,2-difluoro-4-(trifluoromethoxyl)benzene;Benzene,1,2-difluoro-3-(trifluoromethoxy);1-Trifluoromethoxy-2,3-difluorobenzene

Molecular Formula:C₇H₃F₅O

Molecular Weight:198.09000

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:9.23000

Exact Mass:198.01000

LogP:2.86340

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1,2-DIFLUORO-4-TRIFLUOROMETHOXYBENZENE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-Trifluoromethoxy-2,3-difluorobenzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,2-DIFLUORO-4-TRIFLUOROMETHOXYBENZENE Use and application,1,2-DIFLUORO-4-TRIFLUOROMETHOXYBENZENE technical grade,usp/ep/jp grade.

Related News: ��Administrative Measures for the Joint Review, Review and Approval of Raw Materials, Medicinal Auxiliaries and Pharmaceutical Packaging Materials and Pharmaceutical Preparations�� (Consultation Draft) issued by the State Food and Drug Administration in December 2017. Supervision departments no longer accept applications for registration of APIs, pharmaceutical excipients, and packaging materials. 1,2-difluoro-4-(trifluoromethoxy)benzene manufacturer The downstream industry of the pharmaceutical intermediate industry is mainly the production of APIs, and the relationship between APIs and preparations is in the upstream and downstream industry chain. The consumer demand for downstream preparations will directly affect the demand for APIs. 1,2-difluoro-4-(trifluoromethoxy)benzene supplier However, in the long run, as the bulk API market continues to fall, more and more companies will transition to specialty API companies, and competition will intensify in the future. 1,2-difluoro-4-(trifluoromethoxy)benzene vendor The outlook for a cure is clouded with theoretical uncertainties and high-profile failures. Pharmaceutical giants including Johnson & Johnson, Merck and Pfizer have ditched their projects on unsatisfactory data. 1,2-difluoro-4-(trifluoromethoxy)benzene factory The downstream industry of the pharmaceutical intermediate industry is mainly the production of APIs, and the relationship between APIs and preparations is in the upstream and downstream industry chain. The consumer demand for downstream preparations will directly affect the demand for APIs.